Genovation Diagnostic PVT LTD

Clinical Exome Sequencing

Clinical Exome Sequencing identifies genetic mutations linked to inherited diseases, enabling accurate diagnosis and personalized treatment for improved patient care.

Understading of Clinical Exome Sequencing

Clinical Exome Sequencing (CES) is a remarkable diagnostic tool that allows for an in-depth look at the protein-coding regions of our genome, known as the exome. By sequencing around 1-2% of the human genome, CES sheds light on genetic mutations linked to a variety of inherited diseases and conditions. It’s a pivotal technology in the realm of personalized medicine, supporting precise diagnosis, prognosis, and treatment choices. Genovation Diagnostic Pvt Ltd stands out as a leader in providing high-quality Clinical Exome Sequencing services, giving healthcare professionals the crucial genetic insights they need to enhance patient care and achieve better treatment results.

product-image

What is Clinical Exome Sequencing?

Clinical Exome Sequencing (CES) is a targeted approach that focuses on the protein-coding regions of roughly 20,000 genes within the human genome. These regions, referred to as exons, make up less than 2% of the genome but are responsible for nearly 85% of known disease-causing mutations.

CES is essential for identifying genetic variants related to inherited diseases, unexplained medical conditions, developmental issues, and rare syndromes. By analyzing the coding regions that are most pertinent to clinical outcomes, CES provides a cost-effective and highly informative solution for thorough genetic testing.

Why Clinical Exome Sequencing is Essential in Clinical Diagnosis

  • Comprehensive Disease Detection: With the capability to examine over 20,000 protein-coding genes, CES provides a more comprehensive approach to identifying genetic mutations tied to a range of inherited conditions. This includes those rare and complex diseases that conventional diagnostic techniques often overlook.
  • Precision Medicine: CES plays a crucial role in tailoring treatment plans to individual needs. By pinpointing specific genetic mutations, healthcare providers can make better-informed choices about treatment options, medication selections, and likely outcomes.
  • Time and Cost-Effective: Clinical Exome Sequencing stands out as a more affordable option compared to whole-genome sequencing, all while still offering precise and reliable results. It also helps to cut down the time needed for diagnosis, which means quicker interventions can take place.
  • Improved Diagnosis of Rare Diseases: When it comes to patients facing rare, undiagnosed conditions, Clinical Exome Sequencing shines by providing a greater chance of diagnosis, giving hope where other tests may not succeed. This method can pinpoint genetic mutations that cause rare diseases, which might otherwise go undetected.
  • Family Planning and Carrier Screening: CES can be a vital resource for anyone planning to start a family. By revealing carrier status for various inherited diseases, it helps potential parents understand their genetic risks and empowers them to make informed choices.
  • Non-invasive and Minimally Disruptive: CES typically requires a simple blood or saliva sample, making it a minimally invasive method for genetic testing.

How Genovation Diagnostic Pvt Ltd Ensures Quality and Accuracy in Clinical Exome Sequencing

At Genovation Diagnostic Pvt Ltd, we leverage advanced technology and the latest in genomics to ensure we deliver the best in clinical diagnostics. Our Clinical Exome Sequencing service is specifically designed to adhere to the high standards of clinical practice, so you can trust that our results are reliable, reproducible, and accurate every time.

  • Advanced Sequencing Platforms: Our approach involves advanced next-generation sequencing (NGS) technologies that facilitate the high-throughput sequencing of extensive exonic regions. With exceptional coverage, accuracy, and sensitivity, our platforms can pinpoint even the most elusive genetic variants.
  • Comprehensive Data Analysis: After sequencing the exomes, our skilled bioinformaticians get to work analyzing the data with computational tools. We interpret the genetic variants using clinical databases, ensuring that the results we provide are clinically relevant and can be seamlessly integrated into patient care.
  • Customized Reports: At Genovation, we get that every patient is different. That’s why we deliver customized and clinically actionable reports that are specifically crafted to meet each patient’s unique needs. Our reports are easy to read, with straightforward recommendations for clinicians, making it simple to incorporate them into the treatment process.
  • Clinical Interpretation of Results: We work with experienced genetic counselors and medical professionals to ensure that the results are clinically actionable and useful. This collaborative approach guarantees that patients receive the most accurate interpretation and appropriate guidance regarding their diagnosis.
  • Ethical and Confidential: We are dedicated to maintaining the highest ethical standards and ensuring patient confidentiality throughout the testing process. Our laboratory complies with all relevant regulations, including those set by the Indian Council of Medical Research (ICMR), to uphold ethical guidelines and protect your privacy.
  • Rapid Turnaround Times: With the advanced infrastructure at Genovation Diagnostic Pvt Ltd, we ensure fast turnaround times, usually delivering results within 3 to 4 weeks. This quick response allows healthcare providers to make prompt and accurate diagnoses, helping to reduce the time it takes to begin treatment.

Applications of Clinical Exome Sequencing

  • Genetic Disorders: CES is a powerful tool for diagnosing genetic disorders like cystic fibrosis, Duchenne muscular dystrophy, Huntington’s disease, and various other inherited conditions. It plays a crucial role in pinpointing mutations within the coding regions of the genes linked to these diseases.
  • Cancer Genomics: Clinical Exome Sequencing is key to detecting the genetic mutations that lead to cancer. By identifying mutations in genes linked to cancer, CES helps oncologists pinpoint potential therapeutic targets and personalize treatment approaches, such as targeted therapies and immunotherapies.
  • Rare Diseases: A lot of rare diseases are linked to mutations in certain genes that typical testing might not catch. CES takes a more in-depth look at rare disease diagnosis, especially when the condition remains undiagnosed through standard methods.
  • Neurological Disorders: Many neurological disorders, like epilepsy, neurodegenerative diseases, and developmental delays, often have links to genetic mutations. CES can play a crucial role in uncovering the genetic origins of these conditions, which makes it easier to diagnose and take action early on.
  • Prenatal Screening: CES can be used for prenatal screening to detect genetic abnormalities in a fetus, allowing parents to make informed decisions early in the pregnancy.
  • Cardiovascular Diseases: Mutations in certain genes have been linked to inherited cardiovascular conditions, including familial hypercholesterolemia, arrhythmias, and cardiomyopathies. CES helps doctors detect these mutations sooner, paving the way for better management and treatment strategies.

Genovation Diagnostic Pvt. Ltd.: Your Partner in Genetic Insight

At Genovation Diagnostic Pvt. Ltd., we are committed to making advanced genomics accessible, affordable, and accurate. Our Clinical Exome Sequencing service is powered by:

  • Next-Generation Sequencing (NGS) Technology
  • Rigorous Bioinformatics Pipelines
  • Expert Genetic Interpretation
  • Clinically Validated Gene Panels
  • Stringent Quality Control Measures

Our highly skilled team of molecular biologists, bioinformaticians, and clinical geneticists ensures that every sample is handled with the utmost precision—from DNA extraction to final clinical reporting.

Features of Our Clinical Exome Sequencing Services:

  • High-Quality Sequencing: We use top-tier NGS platforms (e.g., Illumina) for high-depth sequencing of exonic regions, ensuring accuracy and reproducibility.
  • Clinically Curated Gene Sets: Genovation Diagnostic focuses on disease-associated genes with proven clinical relevance, continuously updating our database as medical genetics evolves.
  • In-Depth Variant Analysis: Advanced algorithms are employed to detect single nucleotide variants (SNVs), small insertions/deletions (indels), and potentially pathogenic mutations.
  • Genetic Counselling Support: We offer pre- and post-test genetic counseling to help patients and physicians interpret and act upon test results responsibly.
  • Comprehensive Clinical Reports: Our reports are clear, actionable, and formatted in accordance with international guidelines such as ACMG (American College of Medical Genetics and Genomics).

The Genovation CES Workflow

Step: 1 Sample Collection

  • Blood, saliva, or buccal swab samples are collected under standardized protocols.

Step: 2 DNA Extraction and QC

  • High-quality genomic DNA is extracted and quality-checked.

Step: 3 Library Preparation & Target Capture

  • Libraries are enriched for clinically relevant exonic regions.

Step: 4 Next-Generation Sequencing

  • Deep sequencing is performed using Illumina or equivalent platforms.

Step: 5 Bioinformatics Analysis

  • Variant calling, annotation, and filtration using validated software pipelines.

Step: 6 Clinical Interpretation & Reporting

  • Variants are classified (pathogenic, likely pathogenic, VUS, benign), and a detailed clinical report is generated.

Step: 7 Post-Test Support

  • Genetic counselling and clinician guidance are provided

Looking Ahead: The Future of Genetic Diagnostics

Clinical Exome Sequencing is a revolutionary technology that’s always advancing. As we deepen our understanding of the human genome and as sequencing technologies grow more sophisticated and accessible, CES is bound to become an even more integral part of routine clinical practice. At Genovation Diagnostic Pvt Ltd, we’re committed to being at the forefront of these innovations, consistently refining our services to provide the most comprehensive, precise, and impactful genetic insights for our patients and the healthcare community.

By tapping into the potential of Clinical Exome Sequencing, we’re uncovering the secrets within our DNA, leading us into a new era of precision healthcare and improved patient outcomes.